Ran Zhong
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Muscle Physiology and Disorders 5
- RNA Research and Splicing 3
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Wenhua Liang (44 shared papers)Jianxing He (40 shared papers)Caichen Li (33 shared papers)Bo Cheng (20 shared papers)Shan Xiong (22 shared papers)Jianfu Li (24 shared papers)Dahai Zhu (10 shared papers)Xiuyu Cai (10 shared papers)
- Journals
- Translational Lung Cancer Research (9 papers)Annals of Translational Medicine (4 papers)Journal of Cancer Research and Clinical Oncology (3 papers)The Analyst (2 papers)Clinical and Translational Medicine (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ran Zhong
62 papers receiving 1.5k citations
Ran Zhong's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 261
- Oncology 388
- Pulmonary and Respiratory Medicine 286
- Immunology 193
- Molecular Biology 464
Countries citing papers authored by Ran Zhong
This map shows the geographic impact of Ran Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Zhong more than expected).
Fields of papers citing papers by Ran Zhong
This network shows the impact of papers produced by Ran Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Zhong. The network helps show where Ran Zhong may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis Hit paper breakdown → | 2021 | 222 |
| 2 | 2017 | 144 | |
| 3 | 2022 | 66 | |
| 4 | 2022 | 60 | |
| 5 | 2015 | 58 | |
| 6 | 2015 | 56 | |
| 7 | 2016 | 55 | |
| 8 | 2023 | 53 | |
| 9 | 2023 | 47 | |
| 10 | 2021 | 43 | |
| 11 | 2020 | 41 | |
| 12 | 2021 | 40 | |
| 13 | 2019 | 39 | |
| 14 | 2020 | 37 | |
| 15 | 2023 | 35 | |
| 16 | 2021 | 27 | |
| 17 | 2014 | 26 | |
| 18 | 2023 | 25 | |
| 19 | 2023 | 21 | |
| 20 | 2018 | 21 |
About Ran Zhong
Ran Zhong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 66 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Muscle Physiology and Disorders (5 papers), Transplantation: Methods and Outcomes (4 papers), Biosensors and Analytical Detection (3 papers), RNA Research and Splicing (3 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (388 citations), Pulmonary and Respiratory Medicine (286 citations), Immunology (193 citations) and Molecular Biology (464 citations). Ran Zhong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenhua Liang, Jianxing He, Caichen Li, Bo Cheng, Shan Xiong, Jianfu Li, Dahai Zhu, Xiuyu Cai, Changyin Li and Jiao Meng. Their work appears in journals such as Translational Lung Cancer Research, Annals of Translational Medicine, Journal of Cancer Research and Clinical Oncology, The Analyst and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.